H.R. 133 · 118th Congress
Mandating Exclusive Review of Individual Treatments Act
- Stage
- Reported from committee
- Sponsor
- Vern Buchanan
- Introduced
- 2023-01-09
- Latest action
- 2024-12-19 · Committee on Ways and Means discharged.
Summary
Mandating Exclusive Review of Individual Treatments (MERIT) Act
This bill specifies that coverage determinations for drugs and biologics under Medicare must be made with respect to each drug or biologic, rather than with respect to a class of drugs or biologics.